Interactions of Flavones and Other Phytochemicals with Adenosine Receptors

  • Kenneth A. JacobsonEmail author
  • Stefano Moro
  • John A. Manthey
  • Patrick L. West
  • Xiao-duo Ji
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 505)


Dietary flavonoids have varied effects on animal cells, such as inhibition of platelet binding and aggregation, inhibition of inflammation, and anticancer properties, but the mechanisms of these effects remain largely unexplained. Adenosine receptors are involved in the homeostasis of the immune, cardiovascular, and central nervous systems, and adenosine agonists/antagonists exert many similar effects. The affinity of flavonoids and other phytochemicals to adenosine receptors suggests that a wide range of natural substances in the diet may potentially block the effects of endogenous adenosine. We used competitive radioligand binding assays to screen flavonoid libraries for affinity and a computational CoMFA analysis of flavonoids to compare steric and electrostatic requirements for ligand recognition at three subtypes of adenosine receptors. Flavone derivatives, such as galangin, were found to bind to three subtypes of adenosine receptors in the µM range. Pentamethylmorin (Ki 2.65 µM) was 14- to 17-fold selective for human A3, receptors than for A1, and A2A receptors. An isoflavone, genistein, was found to bind to A1, receptors. Aurones, such as hispidol (Ki 350 nM) are selective A1, receptor antagonists, and, like genistein, are present in soy. The flavones, chemically optimized for receptor binding, have led to the antagonist, MRS 1067 (3,6-dichloro-2’-(isopropoxy)-4’-methylflavone), which is 200-fold more selective for human A3 than A1, receptors. Adenosine receptor antagonism, therefore, may be important in the spectrum of biological activities reported for the flavonoids.


Adenosine Receptor Adenosine Receptor Antagonist Endogenous Adenosine Comparative Molecular Field Analysis Structure Activity Relationship 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Barnes, S., Kim, H., Darley-Usmar, V.. Patel, R., Xu, J., Boersma, B., and Luo, M., 2000, Beyond ERa and ERb: Estrogen receptor binding is only part of the isoflavone story. J. Nutr. 130: 656S - 657S.Google Scholar
  2. Beaven, M. A., Ramkumar, V.. and Ali, H.. 1994. Adenosine A, receptors in mast cells, Trends Pharmacol Sci. 15: 1314.CrossRefGoogle Scholar
  3. Beretz, A., and Cazenave, J. P., 1988, The effect offlavonoids on blood-vessel wall interactions, In Plant Flavonoids in Biology and Medicine II: Biochemical. Cellular, and Medicinal Properties. Cody, V. Middleton, E., Jr., Harborne, and J. B., Beretz, A., eds., Alan R. Liss, New York, pp. 187–200.Google Scholar
  4. Coward, L.. Barnes, N., Setchell, K., and Barnes, S., 1993, Genistein, daidzein, and their B-glycoside conjugates: antitumor isoflavones in soybean foods from American and Asian diets, J. Agric. Food Chen. 41: 1961–1967.Google Scholar
  5. Dai, R., Jacobson, K. A., Robinson, R. C., and Friedman, F. K., 1997, Differential effects of flavonoids on testosterone- metabolizing cytochrome P450s, Life Sciences. Pharmacology Letters 61:PL75–PL80.Google Scholar
  6. Hasrat, J. A., De Bruyne, T., DeBacker, J. P., Vauquelin, G., and Vlietinck, A. J., 1997, Cirsimarin and cirsimaritin, flavonoids of Microtea debilis (Phytolaccaceae) with adenosine antagonistic properties in rats: leads for new therapeutics in acute renal failure. J Pharm. Pharmacol. 49: 1150–1156.CrossRefGoogle Scholar
  7. Jacobson, K. A., Kim, H. O., Siddiqi, S. M., Olah, M. E., Stiles, G., and von Lubitz, D. K. J. E., 1995, A3 adenosine receptors: Design of selective ligands and therapeutic prospects, Drugs of the Future 20: 689–699.Google Scholar
  8. Jacobson, K. A., Park, K. S., Jiang, J. -I., Kim, Y. -C., Olah, M. E., Stiles, G. L., and Ji, X. D., 1997, Pharmacological characterization of novel A3 adenosine receptor-selective antagonists. Neuropharmacology 36: 1157–1165.CrossRefGoogle Scholar
  9. Jacobson, K. A., and Suzuki, F., 1997, Recent developments in selective agonists and antagonists acting at purine and pyrimidine receptors, Drug Devel. Res. 39: 289–300.CrossRefGoogle Scholar
  10. Ji, X. D., Melman, N., and Jacobson, K. A., 1995, Interactions of flavonoids and other phytochemicals with adenosine receptors, J. Med Chem. 39: 781–788.CrossRefGoogle Scholar
  11. Karton, Y., Jiang, J. L., Ji, X. D., Melman, N., Olah, M. E., Stiles, G. L., and Jacobson, K. A., 1996, Synthesis and biological-activities of flavonoid derivatives as adenosine receptor antagonists, J. Med. Chem. 39: 2293–2301.CrossRefGoogle Scholar
  12. Limasset, B., le Doucen, C., Dore, J. C., Ojasoo, T., Damon, M., and Crastes de Paulet, A., 1993, Effects of flavonoids on the release of reactive oxygen species by stimulated human neutrophils: Multivariate analysis of structure-activity relationships (SAR), Biochem. Pharmacol. 46: 1257–1271.CrossRefGoogle Scholar
  13. Manthey, J. A., 2000, Biological properties of flavonoids pertaining to inflammation, Microcirculation 7: S29 - S34.CrossRefGoogle Scholar
  14. Middleton, E. Jr., 1988, Some biological properties of plant flavonoids, Ann. Allergy 61: 53–57.Google Scholar
  15. Middleton, E. Jr., and Ferriola, P., 1988, Effect offlavonoids on protein kinase C: relationship to inhibition of human basophil histamine release, In Plant Flavonoids in Biology and Medicine II: Biochemical, Cellular, and Medicinal Properties. Cody, V. Middleton, E., Jr., Harborne, J. B., and Beretz, A., Eds., Alan R. Liss: New York, NY, pp. 251–266.Google Scholar
  16. Moro, S., Van Rhee, A. M., Sanders, L. H., and Jacobson, K. A., 1998, Flavonoid derivatives as adenosine receptor antagonists: A comparison of the hypothetical receptor binding site based on a comparative molecular field analysis model, J. Med Chem 41: 46–52.CrossRefGoogle Scholar
  17. Müller, C., 1997, Al adenosine receptor antagonists, Exp. Opin. Ther. Patents 7: 419–440.CrossRefGoogle Scholar
  18. Okajima, F., Akbar, M., Abdul Majid, M., Sho, K., Tomura, H., and Kondo, Y., 1994, Genistein, an inhibitor of protein tyrosine kinase, is also a competitive antagonist for P,-purinergic (adenosine) receptor in FRTL-5 thyroid cells, Biochem. Biophvs. Res. Comm. 203: 1488–1495.CrossRefGoogle Scholar
  19. Raghavan, K., Buolamwini, J. K., Kohn, K. W., and Weinstein, J. N., 1995, Three dimensional quantitative structure-activity relationship (QSAR) of HIV integrase inhibitors: A comparative molecular field analysis (CoMFA) Study, J. Med. Chem. 38: 890–897.Google Scholar
  20. Sajjadi, F. G., Takabayashi, K., Foster, A. C., Domingo, R. C., and Firestein, G. S., 1996, Inhibition ofTNF-a expression by adenosine–Role of A, adenosine receptors, J. Immunol. 156: 3435–3442.Google Scholar
  21. Setchel, K, D., 1996, Overview of isoflavone structure, metabolism, and pharmacokentics, From the Second International Symposium on the Role ofSoy in Preventing and Treating Chronic Disease., Brussels, Belgium. September 15–18, 1996.Google Scholar
  22. Shin, Y., Daly, J. W., and Jacobson, K. A., 1996, Activation of phosphoinositide breakdown in a rat RBL-2H3 mast cell line by adenosine analogues: Lack of correlation with affinity for A,-adenosine receptor, Drug Devel. Res. 39: 36–46.CrossRefGoogle Scholar
  23. Strickler, J., Jacobson, K. A., and Liang, B. T., 1996, Direct preconditioning of cultured chick ventricular myocytes: Novel functions of cardiac adenosine A,A and A, receptors, J. Clin. Invest. 98: 1773–1779.CrossRefGoogle Scholar
  24. von Lubitz, D. K. J. E., Lin, R. C. S., Popik, P., Carter, M. F., and Jacobson, K. A., 1994, Adenosine Al receptor stimulation and cerebral ischemia, Eur. J. Pharmacol. 263: 59–67.CrossRefGoogle Scholar
  25. Wang, H. K., Yang, Z., Natschke, S. L. M., and Lee, K. H.. 1998, Recent advances in the discovery and development offlavonoids and their analogues as anti-tumor and anti-HIV agents, In Advances in Experimental Medicine and Biology: Flavonoids in the Living System, Manthey, J. A., and Buslig, B. S., eds, Plenum Press, New York, NY pp. 191–227.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Kenneth A. Jacobson
    • 1
    Email author
  • Stefano Moro
    • 1
    • 2
  • John A. Manthey
    • 3
  • Patrick L. West
    • 1
  • Xiao-duo Ji
    • 1
  1. 1.Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes, Digestive and Kidney DiseasesNational Institutes of HealthBethesdaUSA
  2. 2.Pharmaceutical Science DepartmentUniversity of PadovaItaly
  3. 3.U.S. Department of Agriculture, Agricultural Research ServiceU.S. Citrus and Subtropical Products LaboratoryWinter HavenUSA

Personalised recommendations